Product Name

  • Name

    Lincomycin hydrochloride

  • EINECS 212-726-7
  • CAS No. 859-18-7
  • Article Data1
  • CAS DataBase
  • Density ==
  • Solubility Soluble in water.
  • Melting Point 156-158 °C
  • Formula C18H34N2O6S.HCl
  • Boiling Point 646.8 °C at 760 mmHg
  • Molecular Weight 443.005
  • Flash Point 345 °C
  • Transport Information
  • Appearance Crystalline
  • Safety 26-36
  • Risk Codes 36/37/38-20/21/22
  • Molecular Structure Molecular Structure of 859-18-7 (Lincomycin hydrochloride)
  • Hazard Symbols HarmfulXn, IrritantXi
  • Synonyms D-erythro-D-galacto-Octopyranoside,methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-,monohydrochloride, trans-a- (8CI);D-erythro-a-D-galacto-Octopyranoside, methyl6,8-dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-,monohydrochloride, (2S-trans)-;D-erythro-a-D-galacto-Octopyranoside, methyl6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-,monohydrochloride (9CI);Lincomycin hydrochloride (7CI);Lincocin;Lincogap;NSC 70731;U 10149a;Lincocin Hydrochloride;
  • PSA 147.79000
  • LogP 0.27380

Synthetic route

lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

Conditions
ConditionsYield
With ammonium hydroxide; dihydrogen peroxide; acetonitrile In water at 20℃; for 0.333333h; pH=10.8;95%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

C30H66N2O6SSi4

C30H66N2O6SSi4

Conditions
ConditionsYield
With pyridine at 2 - 20℃; for 8h;89%
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

clindamycin hydrochloride monohydrate

clindamycin hydrochloride monohydrate

Conditions
ConditionsYield
In water86%
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

A

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfinyl-tetrahydro-pyran-2-yl)-propyl]-amide

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfinyl-tetrahydro-pyran-2-yl)-propyl]-amide

B

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

Conditions
ConditionsYield
With ammonium hydroxide; dihydrogen peroxide In water at 20℃; for 12h; pH=10.8;A 66%
B 30%
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

Methyl 6-Amino-6,8-dideoxy-1-thio-D-erythro-α-D-galacto-octopyranoside
14810-93-6

Methyl 6-Amino-6,8-dideoxy-1-thio-D-erythro-α-D-galacto-octopyranoside

Conditions
ConditionsYield
With hydrazine hydrate at 120℃; for 24h;59%
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

A

(1R,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

(1R,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

B

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

(1S,2S,4R)-1-Methyl-1-oxy-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methanesulfonyl-tetrahydro-pyran-2-yl)-propyl]-amide

Conditions
ConditionsYield
With sodium hydroxide; dihydrogen peroxide In water at 20℃; for 12h; pH=9.75;A 47%
B 50%
D-Mannose
530-26-7

D-Mannose

lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

(2S,4R)-1-Methyl-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide

(2S,4R)-1-Methyl-4-propyl-pyrrolidine-2-carboxylic acid [(1R,2R)-2-((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide

Conditions
ConditionsYield
With α-mannosidase In various solvent(s) at 48℃; pH=5.0; Enzymatic reaction;2.4%
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C26H50N2O6S

C26H50N2O6S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / 24 h / 120 °C
2: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
3: trifluoroacetic acid / dichloromethane / 2 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C31H58N2O8S

C31H58N2O8S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine hydrate / 24 h / 120 °C
2: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C9H18ClNO4S

C9H18ClNO4S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine hydrate / 24 h / 120 °C
2: triphenylphosphine; tetrachloromethane / acetonitrile / 3 h / Reflux
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C26H39ClN2O5S

C26H39ClN2O5S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: hydrazine hydrate / 24 h / 120 °C
2.1: triphenylphosphine; tetrachloromethane / acetonitrile / 3 h / Reflux
3.1: triethylamine; isobutyl chloroformate / acetonitrile / 1 h / 10 °C
3.2: 18 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C21H31ClN2O5S

C21H31ClN2O5S

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: hydrazine hydrate / 24 h / 120 °C
2: triphenylphosphine; tetrachloromethane / acetonitrile / 3 h / Reflux
3: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 3.5 h / 20 °C
4: trifluoroacetic acid / dichloromethane / 2 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C26H39ClN2O7S

C26H39ClN2O7S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / 24 h / 120 °C
2: triphenylphosphine; tetrachloromethane / acetonitrile / 3 h / Reflux
3: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 3.5 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C20H30ClN3O5S

C20H30ClN3O5S

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: hydrazine hydrate / 24 h / 120 °C
2: triphenylphosphine; tetrachloromethane / acetonitrile / 3 h / Reflux
3: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
4: trifluoroacetic acid / dichloromethane / 2 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C25H38ClN3O7S

C25H38ClN3O7S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / 24 h / 120 °C
2: triphenylphosphine; tetrachloromethane / acetonitrile / 3 h / Reflux
3: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C23H36N2O6S

C23H36N2O6S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / 24 h / 120 °C
2: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
3: trifluoroacetic acid / dichloromethane / 2 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C28H44N2O8S

C28H44N2O8S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine hydrate / 24 h / 120 °C
2: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C23H42N2O6S

C23H42N2O6S

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / 24 h / 120 °C
2: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
3: trifluoroacetic acid / dichloromethane / 2 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C28H50N2O8S

C28H50N2O8S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine hydrate / 24 h / 120 °C
2: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

clindamycin phosphate
24729-96-2

clindamycin phosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: phosgene / chloroform; N,N-dimethyl-formamide / 2 h / 5 - 71 °C / Large scale
1.2: 10 °C / Alkaline conditions; Large scale
2.1: toluene-4-sulfonic acid / acetone / 6 h / 35 °C / Large scale
3.1: triethylamine; trichlorophosphate; 1H-imidazole / acetone / 4 h / 22 °C / Large scale
3.2: 30 °C / Large scale
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

Conditions
ConditionsYield
Stage #1: lincomycin hydrochloride With phosgene In chloroform; N,N-dimethyl-formamide at 5 - 71℃; for 2h; Large scale;
Stage #2: at 10℃; Temperature; Reagent/catalyst; Alkaline conditions; Large scale;
With bis(trichloromethyl) carbonate; ester of 3,5-di-tert-butyl-4-hydroxyphenylpropionic acid and pentaerythritol In chloroform; 1,2-dichloro-ethane; N,N-dimethyl-formamide at 12 - 62℃; for 13h; Temperature; Large scale;
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C21H37ClN2O5S

C21H37ClN2O5S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: phosgene / chloroform; N,N-dimethyl-formamide / 2 h / 5 - 71 °C / Large scale
1.2: 10 °C / Alkaline conditions; Large scale
2.1: toluene-4-sulfonic acid / acetone / 6 h / 35 °C / Large scale
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

7-epiclindamycin hydrochloride

7-epiclindamycin hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: pyridine / 8 h / 2 - 20 °C
2: acetic acid / methanol / 18 h / 30 °C
3: triphenylphosphine; di-isopropyl azodicarboxylate / toluene / 20 h / 30 °C
4: potassium carbonate / methanol / 20 h / 130 °C
5: hydrogenchloride
6: bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; chloroform / 23 h / 5 - 60 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C18H34N2O6S*ClH

C18H34N2O6S*ClH

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: pyridine / 8 h / 2 - 20 °C
2: acetic acid / methanol / 18 h / 30 °C
3: triphenylphosphine; di-isopropyl azodicarboxylate / toluene / 20 h / 30 °C
4: potassium carbonate / methanol / 20 h / 130 °C
5: hydrogenchloride
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

2,3,4-tris-O-(trimethylsilyl)lincomycin
25420-97-7

2,3,4-tris-O-(trimethylsilyl)lincomycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 8 h / 2 - 20 °C
2: acetic acid / methanol / 18 h / 30 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

C34H61N3O9SSi3

C34H61N3O9SSi3

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine / 8 h / 2 - 20 °C
2: acetic acid / methanol / 18 h / 30 °C
3: triphenylphosphine; di-isopropyl azodicarboxylate / toluene / 20 h / 30 °C
View Scheme
lincomycin hydrochloride
859-18-7

lincomycin hydrochloride

lincomycin
154-21-2

lincomycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: pyridine / 8 h / 2 - 20 °C
2: acetic acid / methanol / 18 h / 30 °C
3: triphenylphosphine; di-isopropyl azodicarboxylate / toluene / 20 h / 30 °C
4: potassium carbonate / methanol / 20 h / 130 °C
View Scheme

Lincomycin hydrochloride Specification

The Lincomycin hydrochloride, with the CAS registry number 859-18-7, is also known as Lincomycin hydrochloride BP98; Lincocin; Lincorex; Lincomycin hydrochloride monohydrate. It belongs to the product categories of Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals.Its EINECS number is 212-726-7.This chemical's molecular formula is C18H34N2O6S.HCl and molecular weight is 443.00. What's more,Its systematic name is D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-,monohydrochloride, trans-alpha-.It is a Crystalline Solid.And it is an antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.

Physical properties about Lincomycin hydrochloride are:
(1)ACD/LogP: 0.908; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): -1.82; (4)ACD/LogD (pH 7.4): -0.20; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 5.85; (9)#H bond acceptors: 8; (10)#H bond donors: 5; (11)#Freely Rotating Bonds: 11; (12)Flash Point: 345 °C; (13)Enthalpy of Vaporization: 109.25 kJ/mol; (14)Boiling Point: 646.8 °C at 760 mmHg; (15)Vapour Pressure: 1.85E-19 mmHg at 25°C.

Safety Information of Lincomycin hydrochloride:
The Lincomycin hydrochloride is harmful by inhalation, in contact with skin and if swallowed. It ii Irritating to eyes, respiratory system and skin.When you use it ,wear suitable protective clothing.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES:Cl.O=C(N[C@@H]([C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O)[C@H](O)C)[C@H]2N(C)C[C@H](CCC)C2;
(2)Std. InChI:InChI=1S/C18H34N2O6S.ClH/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25);1H/t9-,10-,11+,12-,13+,14-,15-,16-,18-;/m1./s1;
(3)Std. InChIKey:POUMFISTNHIPTI-BOMBIWCESA-N.

The toxicity data of Lincomycin hydrochloride as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD oral > 300mg/kg (300mg/kg)   Toxicology and Applied Pharmacology. Vol. 6, Pg. 476, 1964.
guinea pig LD50 intraperitoneal 732mg/kg (732mg/kg)   Bulletin of the Faculty of Pharmacy Vol. 18, Pg. 131, 1979.
monkey LD oral > 300mg/kg (300mg/kg)   Toxicology and Applied Pharmacology. Vol. 6, Pg. 476, 1964.
mouse LD50 intramuscular > 5gm/kg (5000mg/kg)   Drugs in Japan Vol. -, Pg. 1260, 1990.
mouse LD50 intraperitoneal 750mg/kg (750mg/kg)   Bulletin of the Faculty of Pharmacy Vol. 18, Pg. 131, 1979.
mouse LD50 intravenous 214mg/kg (214mg/kg)   Toxicology and Applied Pharmacology. Vol. 6, Pg. 476, 1964.
mouse LD50 oral > 5gm/kg (5000mg/kg)   Drugs in Japan Vol. -, Pg. 1260, 1990.
mouse LD50 subcutaneous > 5gm/kg (5000mg/kg)   Drugs in Japan Vol. -, Pg. 1260, 1990.
rat LD50 intravenous 342mg/kg (342mg/kg)   Toxicology and Applied Pharmacology. Vol. 6, Pg. 476, 1964.
rat LD50 oral > 5gm/kg (5000mg/kg)   Drugs in Japan Vol. -, Pg. 1260, 1990.
rat LD50 subcutaneous 9778mg/kg (9778mg/kg)   Toxicology and Applied Pharmacology. Vol. 9, Pg. 445, 1966.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View